Skip to main content
SpringerLink
Log in

PIPERACILLIN HAS YET TO PROVE ITSELF MORE USEFUL THAN AZLOCILLIN OR MEZLOCILLIN

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

PIPERACILLIN HAS YET TO PROVE ITSELF MORE USEFUL THAN AZLOCILLIN OR MEZLOCILLIN. Inpharma Wkly. 406, 3 (1983). https://doi.org/10.1007/BF03304006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03304006

Keywords

Search

Navigation